Jamie M. White is a passionate mission-driven health science strategist and advisor, who is proud to be the Founder and CEO of innovative Health Science (iHS) Strategies, LLC. She looks forward to continuing to work across sectors, ranging from government to philanthropy to industry to academia to advocacy, in her pursuit of creating cross-sector and multinational partnerships that better health. Previously, she acted as the Health Science Strategy and Relations Lead and a Health Science Policy Analyst at the National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH). In this position, she provided strategic guidance to leadership concerning policy and programmatic challenges in science, health, and the biomedical workforce that were of significance to the agency. In addition, she conducted a wide range of staff functions involving strategy, visioning, and process planning, as well as created and sustained external and internal partnerships through strategic engagement, including the Innovation Equity Forum (IEF). Jamie began her career at NIH as a Presidential Management Fellow (PMF) – STEM track, serving as the Special Assistant to the Director of ORWH. Prior to working for NIH, she held several additional positions including a Laboratory Analyst at the Blue Grass Chemical Agent-Destruction Pilot Plant (BGCAPP) and a Research Chemist at the Center for Disease Control and Prevention (CDC).
Jamie has published several peer reviewed articles and frequently speaks at both domestic and international forums. She has expertise in multiple disciplines, including global women’s health innovation, sex, gender & intersectionality, precision medicine and personalized care, analytical chemistry, behavioral neuroendocrinology, bioethics, government affairs, and policy. Recently, she was awarded the American Medical Women's Association (AMWA) Presidential Recognition Award, First in Femtech Award, her third NIH Director's Award, and named in the 200 Trailblazing Leaders in Women's Health and FemTech for her work on the Women's Health Innovation Opportunity Map. She attained her graduate degree in neuroscience at Tulane University and is a proud alumna of Spelman College and the Gates Millennium Scholars Program. Currently, she is on the Advisory Board of the Women's Health Innovation Series, member of the MedTech Color Community Collaborative and serves on the XPrize Global Visioneering Brain Trust - Health Domain.
Women’s Health Innovation Opportunity Map 2023: 50 High-Return Opportunities to Advance Global Women’s Health R&D. October 2023. Bill & Melinda Gates Foundation and National Institutes of Health. https://orwh.od.nih.gov/sites/orwh/files/docs/womens-health-rnd-opportunity-map_2023_508.pdf
White, J., Clayton J. The gender health innovation gap: A perspective from the NIH Office of Research on Women’s Health. Med May 2022 3(5):298-301 https://www.cell.com/med/pdf/S2666-6340(22)00176-3.pdf
White, J., Tannenbaum, C., Klinge, I., Schiebinger, L., Clayton, J., The Integration of Sex and Gender Considerations into Biomedical Research: Lessons from International Funding Agencies. The Journal of Clinical Endocrinology and Metabolism. 2021 https://doi.org/10.1210/clinem/dgab434
Thomas, DA, Bruckheim, HE, JM White., The Need to Consider Pregnancy As a Biological Variable to Reduce Preventable Suffering Related to Pregnancy. Journal of Women’s Health, 2021. Vol 30. No.2 https://www.liebertpub.com/doi/10.1089/jwh.2020.8870
Clayton, JA., White, JM., Considering Sex as Biological Variable (SABV). Association for Women in Science Magazine. Fall 2017 (49)
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.